These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15585488)

  • 1. Enhancement of radioiodine treatment of small-pool hyperthyroidism with antithyroid drugs: kinetics and dosimetry.
    Zanzonico PB; Becker DV; Hurley JR
    J Nucl Med; 2004 Dec; 45(12):2102-8. PubMed ID: 15585488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation dose to patients and relatives incident to 131I therapy.
    Zanzonico PB
    Thyroid; 1997 Apr; 7(2):199-204. PubMed ID: 9133684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid echogenicity: A clue to precise individual dosimetry in radioiodine therapy of hyperthyroidism.
    Marković V; Eterović D; Stipanović P; Punda A
    Med Hypotheses; 2011 Feb; 76(2):153-6. PubMed ID: 20889262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodine therapy and thyrostatic drugs and iodine.
    Moka D; Dietlein M; Schicha H
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S486-91. PubMed ID: 12192550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.
    Sabri O; Zimny M; Schreckenberger M; Reinartz P; Ostwald E; Buell U
    Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High failure rates after (131)I therapy in Graves hyperthyroidism patients with large thyroid volumes, high iodine uptake, and high iodine turnover.
    de Jong JA; Verkooijen HM; Valk GD; Zelissen PM; de Keizer B
    Clin Nucl Med; 2013 Jun; 38(6):401-6. PubMed ID: 23579983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine treatment of hyperthyroidism in a pregnant women.
    Berg GE; Nyström EH; Jacobsson L; Lindberg S; Lindstedt RG; Mattsson S; Niklasson CA; Norén AH; Westphal OG
    J Nucl Med; 1998 Feb; 39(2):357-61. PubMed ID: 9476950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioactive iodine therapy in cats with hyperthyroidism.
    Turrel JM; Feldman EC; Hays M; Hornof WJ
    J Am Vet Med Assoc; 1984 Mar; 184(5):554-9. PubMed ID: 6706799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithyroid drug regimens before and after 131I-therapy for hyperthyroidism: evidence-based?
    Mijnhout GS; Franken AA
    Neth J Med; 2008 Jun; 66(6):238-41. PubMed ID: 18689906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different thyroid committed doses in radioiodine therapy for Graves' hyperthyroidism.
    Grosso M; Traino A; Boni G; Banti E; Della Porta M; Manca G; Volterrani D; Chiacchio S; AlSharif A; Borsò E; Raschillà R; Di Martino F; Mariani G
    Cancer Biother Radiopharm; 2005 Apr; 20(2):218-23. PubMed ID: 15869459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration.
    Calegaro JU; De Freitas Gomes E; Bae SH; Ulyssea R; Casulari LA
    Panminerva Med; 2000 Dec; 42(4):241-5. PubMed ID: 11294085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK; Larsen PR
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome.
    Reinhardt MJ; Brink I; Joe AY; Von Mallek D; Ezziddin S; Palmedo H; Krause TM
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1118-24. PubMed ID: 12192554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of factors affecting treatment results for toxic goiter with radioactive 131I].
    Listewnik MH
    Ann Acad Med Stetin; 2000; 46():109-21. PubMed ID: 11712298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characterization of therapy failures in radioiodine therapy of Graves' disease without simultaneous antithyroid agents].
    Sabri O; Zimny M; Schreckenberger M; Reinartz P; Nowak B; Ostwald E; Schäfer W; Block S; Setani K; Büll U
    Nuklearmedizin; 2001 Feb; 40(1):1-6. PubMed ID: 11373933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients.
    Mauguen A; Grewal RK; Augensen F; Abusamra M; Mahajan S; Jayaprakasam VS; Osborne J; Haque S; Wong BZY; Ghossein RA; Fagin J; Schӧder H; Tuttle RM; Ho A; Humm JL; Larson SM
    Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):2971-2983. PubMed ID: 37171634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of time of administration and dietary iodine levels on potassium iodide (KI) blockade of thyroid irradiation by 131I from radioactive fallout.
    Zanzonico PB; Becker DV
    Health Phys; 2000 Jun; 78(6):660-7. PubMed ID: 10832925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Basedown disease, thyroid gland autonomy, nodular goiter. When is radiotherapy indicated?].
    Dietlein M; Schicha H
    MMW Fortschr Med; 2003 Apr; 145(17):47-9. PubMed ID: 12808806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
    Andrade VA; Gross JL; Maia AL
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.